Psychomotor-activating effects mediated by dopamine D2 and D3 receptors in the nucleus accumbens

Pharmacology Biochemistry and Behavior

Volumn 67, Issue 1, 2000, Pages 161-168

  Canales, Juan J ^a,b   Iversen, Susan D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

(+) PD 128907; Behavior; Bromocriptine; D2; D3; Dopamine receptors; L 741 626; Nafadotride; Nucleus accumbens

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 4 (4 CHLOROPHENYL) 1 (1H INDOL 3 YLMETHYL)PIPERIDIN 4 OL; BROMOCRIPTINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; NAFADOTRIDE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RAT; YAWNING;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BEHAVIOR, ANIMAL; BENZOPYRANS; BROMOCRIPTINE; GROOMING; INDOLES; MOTOR ACTIVITY; NAPHTHALENES; NUCLEUS ACCUMBENS; OXAZINES; PIPERIDINES; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 0033666984     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00311-7     Document Type: Article

References (45)

1. 3 receptor ligands
2. 3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat
3. 3 receptor agonist ligand, to CHO-K1 cells
4. 3 dopamine receptor, in rat brain: A receptor binding and quantitative autoradiographic study
5. 3 receptor agonist, (+)-PD 128907, in the rat
6. 2 autoreceptors
7. 3 receptor agonists
8. 3 knock-out and wild-type mice
9. 2 receptor antagonist L-741 626
10. Behavioural topography in the striatum: Differential effects of quinpirole and D-amphetamine microinjections
11. Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors
12. 3 dopamine receptor antagonists using an ethologically based approach
13. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour
14. Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other D-2-like agonists
15. Differential effect of systemic administration of bromocriptine and L-dopa on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats
16. 3 receptor in the rat brain
17. 3 receptor gene is associated with opiate dependence
18. Differential behavioral and biochemical effects of four dopaminergic agonists
19. 3 receptor
20. Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393
21. Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors
22. Time course of bromocriptine induced excitation in the rat: Behavioural and biochemical studies
23. Bromocriptine enhances the behavioural effects of apomorphine and dopamine after systemic or intracerebral injection in rats
24. 3 receptor gene
25. 3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics
26. Non-opiate beta-endorphin fragments and dopamine VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats
27. 3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography
28. 2 dopamine receptors by nafadotride
29. 3 antagonists on spontaneous motor activity and morphine-induced hyperactivity in male mice
30. 2 receptors elicits prolactin secretion and catalepsy
31. 2-receptor antagonists induce catalepsy via different efferent striatal pathways
32. 2 receptors
33. 3 receptor antagonist, activates locomotion in rodents
34. Dopamine receptor pharmacology
35. Molecular neurobiology of dopaminergic receptors
36. 3) as a target for neuroleptics
37. Novel dopamine receptors half a decade later
38. 3 dopamine receptors in the brain reward circuits of human cocaine fatalities
39. 3 receptor gene polymorphism and alcohol dependence: Relation to personality rating
40. Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning
41. 3 receptor function in response to psychostimulants using a genetic approach
42. 3 receptor-selective agonists and antagonists
43. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine